Roivant Sciences Deferred Revenue increased by 161.1% to $3.05M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.4%, from $3.04M to $3.05M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase is generally positive, signaling strong future demand and cash collection, while a decrease indicates the fulfillment of obligations.
This represents payments received from customers for goods or services that have not yet been delivered or performed. It...
Common in subscription and long-term contract businesses; highly indicative of future revenue visibility.
deferred_revenue_current| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.15M | $13.15M | $11.90M | $7.80M | $12.44M | $10.57M | $5.80M | $4.70M | $4.17M | $2.66M | $3.41M | $3.04M | $1.17M | $3.05M |
| QoQ Change | — | +29.6% | -9.5% | -34.5% | +59.6% | -15.1% | -45.1% | -19.0% | -11.2% | -36.2% | +28.2% | -11.0% | -61.5% | +161.1% |
| YoY Change | — | — | — | — | +22.6% | -19.6% | -51.3% | -39.8% | -66.5% | -74.8% | -41.2% | -35.3% | -72.0% | +0.4% |